Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q1 2024 Earnings Call Transcript

Page 2 of 2

Danielle Brill: Understood. Thanks so much.

Brian Goff: Thank you.

Operator: Thank you. And this concludes today’s question-and-answer session. I will now turn the call back to Brian Goff for closing remarks.

Brian Goff: Thanks a lot, Norma and thank you very much everyone for participating in today’s call. I think it’s – I hope it’s clear. It’s a very exciting time at Agios. We believe that we are well poised to deliver transformative new therapies for patients as well as creating significant long-term value to shareholders. So, thanks again and we look forward to speaking with all of you again soon.

Operator: This concludes today’s conference call. Thank you for your participation. You may now disconnect. Everyone, have a wonderful day.

Follow Agios Pharmaceuticals Inc. (NASDAQ:AGIO)

Page 2 of 2